With loosened rules around remote prescriptions, a psychedelic-like drug has become a popular treatment for mental health conditions. But a boom in at-home use has outpaced evidence of safety.
Since some of the key regulatory waivers that fueled this expansion are temporary, the landscape for telehealth providers in 2023 may present new challenges.